Since sialadenitis and xerostomia are common side effects of radioiodine treatment, together with the common expression of NIS, we hypothesize that radioiodine may be an interesting therapeutic option for NIS-positive ACC of the head and neck [6,7]. The gene discussed is SLC5A5; the disease is sialadenitis.